Crinetics Pharmaceuticals, Inc. is a biotech company developing new medicines.
Crinetics Pharmaceuticals, Inc. (CRNX) is expected to report earnings on Thursday, November 5, 2026, after the close. Estimated release time 16:15 ET. Consensus EPS estimate is $-1.20.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-03 | Jun 2026 qtr | $-1.18 | $-1.14 | +3.4% | $25.12M |
| 2026-05-07 | Mar 2026 qtr | $-1.22 | $-1.23 | -0.8% | $10.73M |
| 2026-02-26 | Dec 2025 qtr | $-1.37 | $-1.30 | +5.1% | $6.16M |
| 2025-08-07 | Jun 2025 qtr | $-1.13 | $-1.23 | -8.8% | $1.03M |
| 2025-05-08 | Mar 2025 qtr | $-0.99 | $-1.04 | -5.1% | $361.00K |
| 2024-08-08 | Jun 2024 qtr | $-0.86 | $-0.94 | -9.3% | $399.00K |
| 2024-05-09 | Mar 2024 qtr | $-0.84 | $-0.93 | -10.7% | $640.00K |
| 2023-12-31 | Dec 2023 qtr | — | $-0.89 | — | $0 |
CRNX has beaten consensus EPS in 2 of its last 7 scored quarters.
See CRNX on the live calendar →